LDLVX
Price
$3.87
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
42.34B
LSCSX
Price
$9.21
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
611.9M
Interact to see
Advertisement

LDLVX vs LSCSX

Header iconLDLVX vs LSCSX Comparison
Open Charts LDLVX vs LSCSXBanner chart's image
Lord Abbett Short Duration Income R6
Price$3.87
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets42.34B
Lord Abbett Short Duration Core Bond R4
Price$9.21
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets611.9M
LDLVX vs LSCSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LDLVX vs. LSCSX commentary
Jun 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LDLVX is a Hold and LSCSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
LDLVX has more cash in the bank: 42.3B vs. LSCSX (612M). LDLVX pays higher dividends than LSCSX: LDLVX (5.28) vs LSCSX (4.60). LDLVX was incepted earlier than LSCSX: LDLVX (10 years) vs LSCSX (8 years). LSCSX (0.77) is less costly to investors than LDLVX (0.32). LDLVX is a more actively managed with annual turnover of: 92.00 vs. LSCSX (78.00). LDLVX (0) and LSCSX (0) have matching initial minimum investment requirements. LDLVX annual gain was more profitable for investors over the last year : 5.99 vs. LSCSX (5.51). LDLVX return over 5 years is better than : 13.94 vs. LSCSX (10.98).
LDLVXLSCSXLDLVX / LSCSX
Total Expense Ratio0.320.6549%
Annual Report Gross Expense Ratio0.320.7742%
Fund Existence10 years8 years-
Gain YTD2.5092.102119%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets42.3B612M6,912%
Annual Yield % from dividends5.284.60115%
Returns for 1 year5.995.51109%
Returns for 3 years14.7413.81107%
Returns for 5 years13.9410.98127%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPX2.400.21
+9.59%
Compass Therapeutics
SO89.300.67
+0.76%
Southern Company (The)
ADT8.150.01
+0.12%
ADT
NABL7.51-0.38
-4.82%
N-able
PODC1.87-0.16
-7.88%
PodcastOne